Sepsis-Induced Cardiomyopathy Reviewed: The Case for Early Consideration of Mechanical Support

J Cardiothorac Vasc Anesth. 2022 Oct;36(10):3916-3926. doi: 10.1053/j.jvca.2022.04.025. Epub 2022 Apr 22.

Abstract

Sepsis-induced cardiomyopathy (SCM) is an increasingly recognized problem encountered in critical care medicine. It generally is characterized as a decrease in left, right, or biventricular ejection fraction followed by a recovery of function over a period of days to weeks. Venoarterial extracorporeal membrane oxygenation (ECMO) has been used for the treatment of adults with various etiologies of shock, including cardiogenic and septic shock. This review summarizes current pathophysiologic mechanisms leading to SCM and provides a detection and treatment algorithm for SCM, as well as a discussion about the rationale and recent clinical data surrounding the use of ECMO and other forms of mechanical circulatory support for SCM.

Keywords: ECMO; Echocardiography; Mechanical circulatory support; Sepsis; Septic shock.

Publication types

  • Review

MeSH terms

  • Adult
  • Cardiomyopathies* / complications
  • Cardiomyopathies* / therapy
  • Extracorporeal Membrane Oxygenation* / adverse effects
  • Humans
  • Sepsis* / complications
  • Sepsis* / therapy
  • Shock, Cardiogenic / etiology
  • Treatment Outcome